Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?

[1]  N. Lurie,et al.  Preventive care for women. Does the sex of the physician matter? , 1993, The New England journal of medicine.

[2]  N. Pérez,et al.  Prostate cancer screening practices: differences between clinic and private patients. , 1995, The Mount Sinai journal of medicine, New York.

[3]  R. B. Williams,et al.  Use of prostate-specific antigen for prostate cancer screening in primary care practice. , 1995, Archives of family medicine.

[4]  E. Wagner,et al.  PSA screening: a public health dilemma. , 1995, Annual review of public health.

[5]  E. Greenberg,et al.  Changes in prostate cancer incidence and treatment in USA , 1994, The Lancet.

[6]  J. Oesterling,et al.  Prostate-specific antigen, digital rectal examination, and transrectal ultrasonography: their roles in diagnosing early prostate cancer. , 1993, Mayo Clinic proceedings.

[7]  Littrup Pj.  The American Cancer Society's National Prostate Cancer Detection Project. , 1994, The Canadian journal of oncology.

[8]  M. Barry,et al.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993, JAMA.

[9]  M. Handley,et al.  The use of prostate specific antigen for prostate cancer screening: a managed care perspective. , 1994, The Journal of urology.

[10]  N. Urban,et al.  Physician gender and screening: do patient differences account for differences in mammography use? , 1997, Women & health.

[11]  S G Pauker,et al.  Screening for prostate cancer. A decision analytic view. , 1994, JAMA.

[12]  J. Oesterling,et al.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.

[13]  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993 .

[14]  S. Woolf,et al.  American College of Preventive Medicine Practice Policy Screening for Prostate Cancer in American Men , 1998 .

[15]  J. Kues,et al.  Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. , 1997, Archives of family medicine.

[16]  M. Rosen.  Impact of prostate-specific antigen screening on the natural history of prostate cancer. , 1995, Urology.

[17]  U. P. S. T. Force.  Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .

[18]  R. Roetzheim,et al.  Physician‐Reported Determinants of Screening Mammography in Older Women: The Impact of Physician and Practice Characteristics , 1995, Journal of the American Geriatrics Society.

[19]  R. Hamm,et al.  Prostate cancer screening. What family physicians believe is best. , 1995, Archives of family medicine.

[20]  W. Phillips,et al.  Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. , 1995, American journal of public health.

[21]  P. Scardino,et al.  Early detection of prostate cancer. , 1989, The Urologic clinics of North America.

[22]  M. Papenfuss,et al.  Attitudes and practices of primary care physicians for prostate cancer screening. , 1996, American journal of preventive medicine.

[23]  R. Kane,et al.  American cancer society–national prostate cancer detection project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen , 1993, Cancer.